Posts by Sean Murphy, MB, BCh, BAO
-
Reverse Cardiac Remodeling May Underlie Benefit of Sacubitril/Valsartan in HFrEF
An exploratory analysis of the PROVE-HF trial of sacubitril/valsartan showed that reductions in biomarkers of myocardial injury correlate with improvements in cardiac remodeling in patients with chronic heart failure—and biomarkers may be capable of guiding short-term follow-up care.
-
Better Prognostic Risk Scoring Needed for Patients with Type 2 Myocardial Infarction
In this first study of its kind, the GRACE, TIMI and TARRACO scores were at best only modestly predictive of adverse outcomes in patients with type 2 myocardial infarction.
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.